<DOC>
	<DOCNO>NCT02312531</DOCNO>
	<brief_summary>In study , HBV-infected pregnant woman divide two group , receive receive hepatitis B immunoglobulin ( HBIG ) pregnancy . In mother , change HBV serum marker ( hepatitis B surface antigen ( HBsAg ) , hepatitis B surface antibody ( HBsAb ) , HBeAg , hepatitis B core antibody ( HBcAb ) ) , DNA load investigate . Immunohistochemical stain custom-made antibody HBIG reveal level distribution HBIG placenta . The protective mechanism HBIG administrate pregnancy explore .</brief_summary>
	<brief_title>Prevention Mother-to-infant Transmission HBV</brief_title>
	<detailed_description>Twenty-eight HBsAg-positive pregnant woman underwent consultation recruit First Affiliated Hospital Xi'an Jiaotong University , Shaanxi , China . Twelve woman willing receive HBIG administration assign experimental group , another sixteen without HBIG injection enrol control group . The exclusion criterion participant : 1 ) infection toxoplasmosis , syphilis , parvovirus B19 , rubella , cytomegalovirus , herpes , hepatitis C , HIV , viruses ; 2 ) obstetric diseases pregnancy-related hypertension , placental abruption , threaten miscarriage , others . The 12 pregnant woman enrol willing receive injection HBIG ( 200 IU , S20023028 , Hualan Biological Engineering Inc. ) begin week 20 gestation ( week 20 , 24 , 28 , 32 , 34 , 36 , 38 , 39 , 40 ) . The control group underwent regular examination without HBIG treatment pregnancy . All infant bear receive combined immunoprophylaxis ( HBIG , 200 IU , first dose hepatitis B vaccine , 5 μg , S19983018 , Shenzhen Kangtai Biological Products Co. Ltd. ) different injection site within 12 h postpartum . Data mother collect medical record include complete healthcare information delivery . Each infant consecutively follow birth , growth index ( weight , length head circumference ) , feed pattern serum level HBV DNA viral marker record . Serum HBV marker ( HBsAg , HBsAb , HBeAg , HBcAb ) titers、HBV DNA load liver function mother regularly measure pregnancy . Serum HBsAg , HBsAb titer HBV DNA load infant test birth , age 7 12 month . Placental tissue section use immunohistochemical staining HBsAg ( mouse , 1:50 , ZM-0122 , Beijing Zhongshan Golden Bridge Biotechnology Co. ) , HBIG ( rabbit , 4.7 mg/ml , 1:2500 , prepare describe ) , CD68 ( mouse , 1:25 , ab955 , Abcam ) . Adverse outcome , HBV infection rate infant , HBV markers titer , liver function HBV DNA load mother , correlation mother newborns regard HBsAb titer histopathological change placenta sample compare experimental group control group . Statistical analysis perform use SPSS 13.0 statistical software ( SPSS Inc. , Chicago , USA ) . Data express mean ± standard deviation ( SD ) . The data analyze Shapiro-Wilk test Levene statistic normality homogeneity variance , respectively . The difference two quantitative group compare independent-sample t-test Mann-Whitney U-test appropriate , correlation analyze Pearson Spearman correlation test . The chi-square test Fisher 's exact test use compare proportion two group . All test two-tailed risk set 5 % , statistical significance set p &lt; 0.05 .</detailed_description>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>HBsAg positive 6 month , gestational age le 20 week infection toxoplasmosis , syphilis , parvovirus B19 , rubella , cytomegalovirus , herpes , hepatitis C , HIV , viruses ; obstetric disease pregnancyrelated hypertension , placental abruption , threaten miscarriage , others .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>HBV</keyword>
	<keyword>Intrauterine infection</keyword>
	<keyword>hepatitis B immunoglobulin</keyword>
	<keyword>immune barrier</keyword>
	<keyword>virus replication</keyword>
	<keyword>placenta</keyword>
</DOC>